Compugen Adds Miriam Merad to Scientific Advisory Board
March 08, 2017 at 07:00 am EST
Compugen Ltd. announced that Miriam Merad, MD, PhD, Director of the Precision Immunology Institute and Co-Leader of the Cancer Immunology program at the Icahn School of Medicine at Mount Sinai in New York, has joined Compugen's Scientific Advisory Board (SAB). Prof. Merad was trained as an oncologist in France and obtained her PhD in immunology at Stanford University and the University of Paris VII. She joined the Icahn School of Medicine at Mount Sinai in 2004 and was promoted to the rank of Full Professor in 2010.